公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2010 | CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells | Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; TSUNG-HAO LIU ; Hou D.-R.; PEI-JER CHEN ; ANN-LII CHENG | Oncogene | 148 | 139 | |
2012 | CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells | Lin Y.-C.; Chen K.-C.; CHING-CHOW CHEN ; ANN-LII CHENG ; Chen K.-F. | Oral Oncology | 54 | 53 | |
1998 | Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancer | ANN-LII CHENG ; KUN-HUEI YEH ; Lin J.-T.; CHIUN HSU ; Liu M.-Y. | Anticancer Research | 23 | 20 | |
2014 | Clinical activity of metronomic chemotherapy in liver cancers | YU-YUN SHAO ; ANN-LII CHENG ; CHIH-HUNG HSU | Metronomic Chemotherapy: Pharmacology and Clinical Applications | 0 | 0 | |
2014 | Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapy | LI-CHUN LU ; YU-YUN SHAO ; Chan S.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG | Anticancer Research | 12 | 10 | |
2010 | Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma | Whang-Peng J.; ANN-LII CHENG ; CHIUN HSU ; Chen C.-M. | Journal of Experimental and Clinical Medicine | 25 | 0 | |
2020 | Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer | WEN-CHI YANG ; Feng-Ming Hsu ; YU-HSUAN CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU ; ZHONG-ZHE LIN ; Lu S.-H.; CHIH-HSIN YANG ; ANN-LII CHENG ; SUNG-HSIN KUO | Clinical and Translational Radiation Oncology | 11 | 8 | |
2016 | Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer | I-CHUN CHEN ; Chang Y.-C.; YEN-SHEN LU ; KUEI-PIN CHUNG ; CHIUN-SHENG HUANG ; TZU-PIN LU ; WEN-HUNG KUO ; Wang M.-Y.; KUAN-TING KUO ; Wu P.-F.; Hsueh T.-H.; Shen C.-Y.; CHING-HUNG LIN ; ANN-LII CHENG | Scientific Reports | 18 | 17 | |
2013 | Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation | CHING-HUNG LIN ; Liu J.M.; YEN-SHEN LU ; Lan C.; Lee W.-C.; KUAN-TING KUO ; Wang C.-C.; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG | Journal of Clinical Pathology | 13 | 14 | |
2007 | Clinical studies with curcumin | CHIH-HUNG HSU ; ANN-LII CHENG | Advances in Experimental Medicine and Biology | 360 | 305 | |
1995 | Clinicopathologic characteristics of helicobacter pyloric seropositive gastric adenocarcinomas | Lee W.-J.; Lin J.-T.; WEN-CHUNG LEE ; CHIA-TUNG SHUN ; RUEY-LONG HONG ; ANN-LII CHENG ; PO-HUANG LEE ; Wei T.-C.; Chen K.-M. | Journal of Clinical Gastroenterology | 13 | 13 | |
2013 | Clinicopathologic features and responses to radiotherapy of myeloid sarcoma | WAN-YU CHEN ; CHUN-WEI WANG ; Chang C.-H.; Liu H.-H.; KENG-HSUEH LAN ; JIH-LUH TANG ; HWEI-FANG TIEN ; SUNG-HSIN KUO ; ANN-LII CHENG | Radiation Oncology | 25 | 25 | |
2009 | Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast - A review of 42 primary and secondary cases in Taiwanese patients | Lin Y.-C.; Tsai C.-H.; Wu J.-S.; CHIUN-SHENG HUANG ; SUNG-HSIN KUO ; CHUNG-WU LIN ; ANN-LII CHENG | Leukemia and Lymphoma | 28 | 21 | |
1996 | Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma: Special emphasis on the tumor response to 13-cis retinoic acid | WEN-CHIEN CHOU ; Su I.-J.; HWEI-FANG TIEN ; Liang D.-C.; Wang C.-H.; Chang Y.-C.; ANN-LII CHENG | Cancer | 43 | ||
2003 | Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age | JIN-TUNG LIANG ; KUO-CHIN HUANG ; ANN-LII CHENG ; YUNG-MING JENG ; MING-SHIANG WU ; Wang S.M. | British Journal of Surgery | 158 | 140 | |
1994 | Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma | MING YAO ; ANN-LII CHENG ; Su I.-J.; Lin M.-T.; Uen W.-C.; HWEI-FANG TIEN ; Wang C.-H.; YAO-CHANG CHEN | British Journal of Haematology | 81 | 66 | |
2001 | Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma | CHIH-HUNG HSU ; Chen J.; Wu C.-Y.; ANN-LII CHENG ; YEONG-SHIAU PU | Anticancer Research | 27 | 24 | |
2002 | Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma | Huang C.-L.; ZHONG-ZHE LIN ; Su I.-J.; Chao T.-Y.; HWEI-FANG TIEN ; Chang M.-C.; Huang M.-C.; Kao W.-Y.; JIH-LUH TANG ; KUN-HUEI YEH ; Wang C.-H.; CHIH-HUNG HSU ; Liu M.-Y.; ANN-LII CHENG | Leukemia and Lymphoma | 9 | 5 | |
2010 | Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma | Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; SUNG-HSIN KUO ; CHIH-HUNG HSU ; YEN-SHEN LU ; ANN-LII CHENG | Cancer Letters | 19 | 19 | |
1996 | Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: A potential use in intravesical chemotherapy | YEONG-SHIAU PU ; Hsieh T.-S.; ANN-LII CHENG ; Tseng N.-F.; Su I.-J.; CHANG-YAO HSIEH ; Lai M.-K.; Tsai T.-C. | British Journal of Urology | 22 | 21 |